Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 9.31722700 |
2 | drug catabolic process (GO:0042737) | 8.72652746 |
3 | * epoxygenase P450 pathway (GO:0019373) | 8.67709285 |
4 | cellular glucuronidation (GO:0052695) | 6.75386373 |
5 | urea metabolic process (GO:0019627) | 6.70434549 |
6 | regulation of fibrinolysis (GO:0051917) | 6.69406096 |
7 | * drug metabolic process (GO:0017144) | 6.60102864 |
8 | * omega-hydroxylase P450 pathway (GO:0097267) | 6.60048015 |
9 | negative regulation of fibrinolysis (GO:0051918) | 6.56862593 |
10 | glucuronate metabolic process (GO:0019585) | 6.46676543 |
11 | uronic acid metabolic process (GO:0006063) | 6.46676543 |
12 | glyoxylate metabolic process (GO:0046487) | 6.36373449 |
13 | regulation of triglyceride catabolic process (GO:0010896) | 6.29650816 |
14 | complement activation, alternative pathway (GO:0006957) | 6.21153468 |
15 | ethanol oxidation (GO:0006069) | 6.15982558 |
16 | nitrogen cycle metabolic process (GO:0071941) | 6.10490511 |
17 | regulation of protein activation cascade (GO:2000257) | 5.96034045 |
18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.94288600 |
19 | L-phenylalanine catabolic process (GO:0006559) | 5.94288600 |
20 | urea cycle (GO:0000050) | 5.85516142 |
21 | regulation of complement activation (GO:0030449) | 5.63959714 |
22 | L-phenylalanine metabolic process (GO:0006558) | 5.52724630 |
23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.52724630 |
24 | bile acid and bile salt transport (GO:0015721) | 5.43871740 |
25 | bile acid metabolic process (GO:0008206) | 5.41966719 |
26 | oxidative demethylation (GO:0070989) | 5.40076398 |
27 | hormone catabolic process (GO:0042447) | 5.36295079 |
28 | negative regulation of sterol transport (GO:0032372) | 5.35303171 |
29 | negative regulation of cholesterol transport (GO:0032375) | 5.35303171 |
30 | fibrinolysis (GO:0042730) | 5.31146221 |
31 | phospholipid efflux (GO:0033700) | 5.22910682 |
32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.21915576 |
33 | protein carboxylation (GO:0018214) | 5.11987452 |
34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.11987452 |
35 | phenylpropanoid metabolic process (GO:0009698) | 5.02050136 |
36 | bile acid biosynthetic process (GO:0006699) | 5.00991883 |
37 | ethanol metabolic process (GO:0006067) | 4.94178254 |
38 | alkaloid metabolic process (GO:0009820) | 4.93939233 |
39 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.92475339 |
40 | angiotensin maturation (GO:0002003) | 4.71734606 |
41 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.70364062 |
42 | blood coagulation, intrinsic pathway (GO:0007597) | 4.68155584 |
43 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.62400046 |
44 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.62400046 |
45 | regulation of cholesterol esterification (GO:0010872) | 4.62362242 |
46 | high-density lipoprotein particle remodeling (GO:0034375) | 4.57602315 |
47 | flavonoid metabolic process (GO:0009812) | 4.47259507 |
48 | cholesterol efflux (GO:0033344) | 4.45358668 |
49 | regulation of bile acid biosynthetic process (GO:0070857) | 4.43375964 |
50 | * fat-soluble vitamin biosynthetic process (GO:0042362) | 4.40406252 |
51 | aromatic amino acid family catabolic process (GO:0009074) | 4.40401355 |
52 | macromolecular complex remodeling (GO:0034367) | 4.39786087 |
53 | plasma lipoprotein particle remodeling (GO:0034369) | 4.39786087 |
54 | protein-lipid complex remodeling (GO:0034368) | 4.39786087 |
55 | triglyceride homeostasis (GO:0070328) | 4.22956378 |
56 | acylglycerol homeostasis (GO:0055090) | 4.22956378 |
57 | intestinal absorption (GO:0050892) | 4.20749692 |
58 | serine family amino acid catabolic process (GO:0009071) | 4.19942222 |
59 | plasma lipoprotein particle assembly (GO:0034377) | 4.19694743 |
60 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.17758150 |
61 | regulation of plasminogen activation (GO:0010755) | 4.14945399 |
62 | heme transport (GO:0015886) | 4.13636695 |
63 | * negative regulation of blood coagulation (GO:0030195) | 4.12145559 |
64 | * negative regulation of hemostasis (GO:1900047) | 4.12145559 |
65 | protein activation cascade (GO:0072376) | 4.09122552 |
66 | fructose metabolic process (GO:0006000) | 4.06526292 |
67 | reverse cholesterol transport (GO:0043691) | 4.05833018 |
68 | amino-acid betaine metabolic process (GO:0006577) | 4.03677839 |
69 | arginine metabolic process (GO:0006525) | 3.97718363 |
70 | intestinal cholesterol absorption (GO:0030299) | 3.92035476 |
71 | complement activation, classical pathway (GO:0006958) | 3.91923757 |
72 | positive regulation of lipid catabolic process (GO:0050996) | 3.89882866 |
73 | lipoprotein transport (GO:0042953) | 3.89228825 |
74 | complement activation (GO:0006956) | 3.85638324 |
75 | NADH metabolic process (GO:0006734) | 3.85507116 |
76 | acute-phase response (GO:0006953) | 3.83818811 |
77 | glycine metabolic process (GO:0006544) | 3.81601737 |
78 | protein-lipid complex assembly (GO:0065005) | 3.75723865 |
79 | * negative regulation of coagulation (GO:0050819) | 3.75401714 |
80 | lipoprotein metabolic process (GO:0042157) | 3.70142117 |
81 | drug transmembrane transport (GO:0006855) | 3.69085259 |
82 | negative regulation of lipase activity (GO:0060192) | 3.68295987 |
83 | * negative regulation of wound healing (GO:0061045) | 3.65790251 |
84 | plasma lipoprotein particle organization (GO:0071827) | 3.60744104 |
85 | glutamate metabolic process (GO:0006536) | 3.59247760 |
86 | regulation of humoral immune response (GO:0002920) | 3.57103979 |
87 | drug transport (GO:0015893) | 3.55900457 |
88 | S-adenosylmethionine metabolic process (GO:0046500) | 3.55535243 |
89 | * xenobiotic metabolic process (GO:0006805) | 3.53635138 |
90 | imidazole-containing compound metabolic process (GO:0052803) | 3.52733703 |
91 | cholesterol homeostasis (GO:0042632) | 3.48343808 |
92 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.44011213 |
93 | sterol homeostasis (GO:0055092) | 3.42339366 |
94 | oxaloacetate metabolic process (GO:0006107) | 3.40592979 |
95 | protein-lipid complex subunit organization (GO:0071825) | 3.40332755 |
96 | positive regulation of hemostasis (GO:1900048) | 3.36086763 |
97 | positive regulation of blood coagulation (GO:0030194) | 3.36086763 |
98 | primary alcohol catabolic process (GO:0034310) | 3.35554857 |
99 | tyrosine metabolic process (GO:0006570) | 3.33678299 |
100 | negative regulation of protein activation cascade (GO:2000258) | 3.33386995 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.68320070 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.09295283 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.74618838 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.20318272 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.08451628 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.35361636 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.15648754 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.42658793 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.24788354 |
10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.92526637 |
11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.87344619 |
12 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.71893888 |
13 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.14144506 |
14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.02915129 |
15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.97267646 |
16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.89717825 |
17 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.78010428 |
18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68627105 |
19 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.65835726 |
20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.61340284 |
21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58284942 |
22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.56902717 |
23 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.56680886 |
24 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.45386541 |
25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.44470632 |
26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42416124 |
27 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.42206412 |
28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35952180 |
29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30740430 |
30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30386711 |
31 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.25817315 |
32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21511233 |
33 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.15730998 |
34 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14446479 |
35 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.13109712 |
36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.10995071 |
37 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08835013 |
38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.05410996 |
39 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.04823120 |
40 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.01534844 |
41 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00450643 |
42 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.98886296 |
43 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97773640 |
44 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97487551 |
45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93389660 |
46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91741725 |
47 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.91149198 |
48 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90220574 |
49 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.89248543 |
50 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.87066389 |
51 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.86769150 |
52 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.86052395 |
53 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85425470 |
54 | CBP_21632823_ChIP-Seq_H3396_Human | 0.84901100 |
55 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.84559999 |
56 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84222913 |
57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83593270 |
58 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.83475734 |
59 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79514459 |
60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.79087315 |
61 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.76436004 |
62 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.73933855 |
63 | AR_20517297_ChIP-Seq_VCAP_Human | 0.71435943 |
64 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.71369755 |
65 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.70492587 |
66 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.70359907 |
67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69474942 |
68 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.69438079 |
69 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.69105447 |
70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69082826 |
71 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.68511338 |
72 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.68493530 |
73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67507045 |
74 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.67440402 |
75 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.66322502 |
76 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.65462370 |
77 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.65141646 |
78 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.64276032 |
79 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.63390963 |
80 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.63311686 |
81 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.63271151 |
82 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.63207787 |
83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62861931 |
84 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.62446389 |
85 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.61666560 |
86 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61529603 |
87 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.61255141 |
88 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.61229298 |
89 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.60674302 |
90 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.60351767 |
91 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.60078773 |
92 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.59822539 |
93 | GATA1_19941826_ChIP-Seq_K562_Human | 0.59470899 |
94 | NFYA_21822215_ChIP-Seq_K562_Human | 0.59083046 |
95 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.58846430 |
96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.58716031 |
97 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.58166206 |
98 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.57650531 |
99 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.57390727 |
100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.56975372 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.84089449 |
2 | MP0005360_urolithiasis | 8.18847481 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.34969417 |
4 | MP0005365_abnormal_bile_salt | 5.68826150 |
5 | MP0001666_abnormal_nutrient_absorption | 4.37588762 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.34418313 |
7 | MP0003252_abnormal_bile_duct | 3.60312410 |
8 | MP0003195_calcinosis | 3.52694047 |
9 | MP0009840_abnormal_foam_cell | 3.36831935 |
10 | MP0002138_abnormal_hepatobiliary_system | 3.13001355 |
11 | MP0003868_abnormal_feces_composition | 3.04479041 |
12 | MP0010329_abnormal_lipoprotein_level | 3.00994563 |
13 | MP0004019_abnormal_vitamin_homeostasis | 2.49308971 |
14 | MP0005332_abnormal_amino_acid | 2.47639835 |
15 | MP0003806_abnormal_nucleotide_metabolis | 2.09984606 |
16 | MP0003191_abnormal_cellular_cholesterol | 1.97589943 |
17 | MP0003183_abnormal_peptide_metabolism | 1.96631274 |
18 | MP0009697_abnormal_copulation | 1.90522969 |
19 | MP0002876_abnormal_thyroid_physiology | 1.85273223 |
20 | MP0000609_abnormal_liver_physiology | 1.78927550 |
21 | MP0002118_abnormal_lipid_homeostasis | 1.74799980 |
22 | MP0001764_abnormal_homeostasis | 1.73616883 |
23 | MP0005670_abnormal_white_adipose | 1.62148107 |
24 | MP0009643_abnormal_urine_homeostasis | 1.47782507 |
25 | MP0004264_abnormal_extraembryonic_tissu | 1.31528172 |
26 | MP0005319_abnormal_enzyme/_coenzyme | 1.14605651 |
27 | MP0005451_abnormal_body_composition | 1.13996063 |
28 | MP0004147_increased_porphyrin_level | 1.13029137 |
29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.11641009 |
30 | MP0005636_abnormal_mineral_homeostasis | 1.08235803 |
31 | MP0003879_abnormal_hair_cell | 1.07041708 |
32 | MP0002971_abnormal_brown_adipose | 1.06260518 |
33 | MP0010155_abnormal_intestine_physiology | 0.92852701 |
34 | MP0010368_abnormal_lymphatic_system | 0.91817512 |
35 | MP0009642_abnormal_blood_homeostasis | 0.90779660 |
36 | MP0009764_decreased_sensitivity_to | 0.89092712 |
37 | MP0000598_abnormal_liver_morphology | 0.87969950 |
38 | MP0005409_darkened_coat_color | 0.87589788 |
39 | MP0008469_abnormal_protein_level | 0.87569429 |
40 | MP0005535_abnormal_body_temperature | 0.84377814 |
41 | MP0005408_hypopigmentation | 0.82908264 |
42 | MP0003718_maternal_effect | 0.78510201 |
43 | MP0005166_decreased_susceptibility_to | 0.77467152 |
44 | MP0005376_homeostasis/metabolism_phenot | 0.74558188 |
45 | MP0002136_abnormal_kidney_physiology | 0.72482820 |
46 | MP0009379_abnormal_foot_pigmentation | 0.72369182 |
47 | MP0002132_abnormal_respiratory_system | 0.71997550 |
48 | MP0005448_abnormal_energy_balance | 0.69844041 |
49 | MP0000604_amyloidosis | 0.68892313 |
50 | MP0003656_abnormal_erythrocyte_physiolo | 0.68763639 |
51 | MP0009763_increased_sensitivity_to | 0.67961380 |
52 | MP0005334_abnormal_fat_pad | 0.66481747 |
53 | MP0008872_abnormal_physiological_respon | 0.65247785 |
54 | MP0005395_other_phenotype | 0.64755737 |
55 | MP0002078_abnormal_glucose_homeostasis | 0.64307202 |
56 | MP0010234_abnormal_vibrissa_follicle | 0.64166740 |
57 | MP0003638_abnormal_response/metabolism_ | 0.63276305 |
58 | MP0009785_altered_susceptibility_to | 0.59627357 |
59 | MP0000566_synostosis | 0.58929696 |
60 | MP0009115_abnormal_fat_cell | 0.58831127 |
61 | MP0005058_abnormal_lysosome_morphology | 0.58115655 |
62 | MP0001756_abnormal_urination | 0.53673926 |
63 | MP0001664_abnormal_digestion | 0.52374899 |
64 | MP0000249_abnormal_blood_vessel | 0.51445233 |
65 | MP0001661_extended_life_span | 0.50316399 |
66 | MP0009053_abnormal_anal_canal | 0.50014088 |
67 | MP0000678_abnormal_parathyroid_gland | 0.49504052 |
68 | MP0000538_abnormal_urinary_bladder | 0.48982190 |
69 | MP0001765_abnormal_ion_homeostasis | 0.48458367 |
70 | MP0002249_abnormal_larynx_morphology | 0.47757184 |
71 | MP0004782_abnormal_surfactant_physiolog | 0.47489318 |
72 | MP0003866_abnormal_defecation | 0.46451241 |
73 | MP0001845_abnormal_inflammatory_respons | 0.45373598 |
74 | MP0005266_abnormal_metabolism | 0.43846338 |
75 | MP0005464_abnormal_platelet_physiology | 0.43454115 |
76 | MP0004043_abnormal_pH_regulation | 0.43075779 |
77 | MP0005666_abnormal_adipose_tissue | 0.42770195 |
78 | MP0009765_abnormal_xenobiotic_induced | 0.41269953 |
79 | MP0003011_delayed_dark_adaptation | 0.41262963 |
80 | MP0003953_abnormal_hormone_level | 0.39886896 |
81 | MP0008874_decreased_physiological_sensi | 0.38983941 |
82 | MP0000477_abnormal_intestine_morphology | 0.37961780 |
83 | MP0005023_abnormal_wound_healing | 0.34375221 |
84 | MP0003436_decreased_susceptibility_to | 0.33939060 |
85 | MP0002822_catalepsy | 0.31897986 |
86 | MP0003690_abnormal_glial_cell | 0.31451947 |
87 | MP0002168_other_aberrant_phenotype | 0.31202781 |
88 | MP0001663_abnormal_digestive_system | 0.29969604 |
89 | MP0003186_abnormal_redox_activity | 0.29668139 |
90 | MP0000230_abnormal_systemic_arterial | 0.28825446 |
91 | MP0006036_abnormal_mitochondrial_physio | 0.27751595 |
92 | MP0001915_intracranial_hemorrhage | 0.27396270 |
93 | MP0001881_abnormal_mammary_gland | 0.26442836 |
94 | MP0009333_abnormal_splenocyte_physiolog | 0.25555796 |
95 | MP0003075_altered_response_to | 0.25148600 |
96 | MP0005164_abnormal_response_to | 0.24647729 |
97 | MP0002970_abnormal_white_adipose | 0.24230482 |
98 | MP0004883_abnormal_blood_vessel | 0.24219775 |
99 | MP0002135_abnormal_kidney_morphology | 0.23291192 |
100 | MP0005025_abnormal_response_to | 0.22741076 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 8.70957019 |
2 | Hypobetalipoproteinemia (HP:0003563) | 8.35216127 |
3 | Deep venous thrombosis (HP:0002625) | 7.75903293 |
4 | Complement deficiency (HP:0004431) | 7.41286062 |
5 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.93246904 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 6.86661744 |
7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.16535752 |
8 | Abnormality of complement system (HP:0005339) | 6.10976337 |
9 | Conjugated hyperbilirubinemia (HP:0002908) | 5.82227650 |
10 | Systemic lupus erythematosus (HP:0002725) | 5.80719057 |
11 | Xanthomatosis (HP:0000991) | 5.32616744 |
12 | Joint hemorrhage (HP:0005261) | 4.81375564 |
13 | Hypolipoproteinemia (HP:0010981) | 4.65485957 |
14 | Hyperlipoproteinemia (HP:0010980) | 4.64504676 |
15 | Fat malabsorption (HP:0002630) | 4.46506053 |
16 | Intrahepatic cholestasis (HP:0001406) | 4.43855796 |
17 | Abnormality of proline metabolism (HP:0010907) | 4.41974110 |
18 | Hydroxyprolinuria (HP:0003080) | 4.41974110 |
19 | Glomerulonephritis (HP:0000099) | 4.24285868 |
20 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.01501081 |
21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.88399030 |
22 | Hyperglycinuria (HP:0003108) | 3.85820266 |
23 | Abnormality of glycine metabolism (HP:0010895) | 3.77818435 |
24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.77818435 |
25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.76185182 |
26 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.44333625 |
27 | Hyperammonemia (HP:0001987) | 3.42571855 |
28 | Malnutrition (HP:0004395) | 3.35290752 |
29 | Steatorrhea (HP:0002570) | 3.30545417 |
30 | Abnormality of vitamin metabolism (HP:0100508) | 3.28127327 |
31 | Nephritis (HP:0000123) | 3.27807824 |
32 | Hemorrhage of the eye (HP:0011885) | 3.13564247 |
33 | Spontaneous abortion (HP:0005268) | 3.10139203 |
34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.08067106 |
35 | Glycosuria (HP:0003076) | 3.05546668 |
36 | Abnormality of urine glucose concentration (HP:0011016) | 3.05546668 |
37 | Rickets (HP:0002748) | 3.04236174 |
38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.00739261 |
39 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.99552621 |
40 | Generalized aminoaciduria (HP:0002909) | 2.98649863 |
41 | Epidermoid cyst (HP:0200040) | 2.95253016 |
42 | Hyperglycinemia (HP:0002154) | 2.93806485 |
43 | Acanthocytosis (HP:0001927) | 2.93659021 |
44 | Hypercholesterolemia (HP:0003124) | 2.86679635 |
45 | Delayed CNS myelination (HP:0002188) | 2.79936235 |
46 | Hyperphosphaturia (HP:0003109) | 2.72025550 |
47 | Widely patent fontanelles and sutures (HP:0004492) | 2.69959127 |
48 | Osteomalacia (HP:0002749) | 2.68307306 |
49 | Vascular calcification (HP:0004934) | 2.68235340 |
50 | Abnormality of purine metabolism (HP:0004352) | 2.54556760 |
51 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.50808133 |
52 | Abnormal urine phosphate concentration (HP:0012599) | 2.48660687 |
53 | Hyperbilirubinemia (HP:0002904) | 2.48273419 |
54 | Metabolic acidosis (HP:0001942) | 2.47957623 |
55 | Proximal tubulopathy (HP:0000114) | 2.45112378 |
56 | Hypoalphalipoproteinemia (HP:0003233) | 2.44502267 |
57 | Gingival bleeding (HP:0000225) | 2.38757232 |
58 | Gout (HP:0001997) | 2.36187400 |
59 | Cardiovascular calcification (HP:0011915) | 2.34564935 |
60 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.34194982 |
61 | Hepatocellular carcinoma (HP:0001402) | 2.32759891 |
62 | Hypophosphatemia (HP:0002148) | 2.32508128 |
63 | Poikilocytosis (HP:0004447) | 2.29963455 |
64 | Facial shape deformation (HP:0011334) | 2.29830908 |
65 | Potter facies (HP:0002009) | 2.29830908 |
66 | Hypophosphatemic rickets (HP:0004912) | 2.29682547 |
67 | Nephrolithiasis (HP:0000787) | 2.28421820 |
68 | Confusion (HP:0001289) | 2.27303178 |
69 | Mitral stenosis (HP:0001718) | 2.26831643 |
70 | Abnormality of serum amino acid levels (HP:0003112) | 2.26771758 |
71 | Abnormality of vitamin B metabolism (HP:0004340) | 2.21135337 |
72 | Irritability (HP:0000737) | 2.14524997 |
73 | Alkalosis (HP:0001948) | 2.14296607 |
74 | Ileus (HP:0002595) | 2.13077140 |
75 | Abnormality of methionine metabolism (HP:0010901) | 2.12441225 |
76 | Pigmentary retinal degeneration (HP:0001146) | 2.12335728 |
77 | Hyperuricemia (HP:0002149) | 2.11912671 |
78 | Increased purine levels (HP:0004368) | 2.11912671 |
79 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.11038371 |
80 | Megaloblastic anemia (HP:0001889) | 2.08435864 |
81 | Elevated alkaline phosphatase (HP:0003155) | 2.06252474 |
82 | Nausea (HP:0002018) | 2.05313475 |
83 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.04925031 |
84 | Purpura (HP:0000979) | 2.01109269 |
85 | Abdominal distention (HP:0003270) | 1.97732584 |
86 | Thrombophlebitis (HP:0004418) | 1.95686605 |
87 | Pancreatitis (HP:0001733) | 1.87882880 |
88 | Chronic diarrhea (HP:0002028) | 1.83962372 |
89 | Focal segmental glomerulosclerosis (HP:0000097) | 1.83224256 |
90 | Pulmonary embolism (HP:0002204) | 1.82388781 |
91 | Cerebral palsy (HP:0100021) | 1.82238247 |
92 | Ketosis (HP:0001946) | 1.82140795 |
93 | Skin nodule (HP:0200036) | 1.80217568 |
94 | Menorrhagia (HP:0000132) | 1.78964876 |
95 | Wide cranial sutures (HP:0010537) | 1.78452769 |
96 | Protuberant abdomen (HP:0001538) | 1.77482450 |
97 | Enlarged kidneys (HP:0000105) | 1.75151254 |
98 | Neonatal hypoglycemia (HP:0001998) | 1.72301259 |
99 | Myocardial infarction (HP:0001658) | 1.71798569 |
100 | Lethargy (HP:0001254) | 1.71670761 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 6.17692675 |
2 | ACVR1B | 5.79054891 |
3 | RIPK1 | 4.15496481 |
4 | FGFR4 | 3.56622595 |
5 | MST1R | 3.18939484 |
6 | PRKG2 | 2.39606929 |
7 | TYK2 | 2.27596374 |
8 | PRPF4B | 2.04148561 |
9 | MAP3K2 | 2.03726362 |
10 | EPHA2 | 1.91441353 |
11 | FGFR3 | 1.84034242 |
12 | EPHA3 | 1.73683589 |
13 | PIK3CG | 1.70328857 |
14 | PIK3CA | 1.62823138 |
15 | MAP3K3 | 1.60529597 |
16 | TRIB3 | 1.55329616 |
17 | PRKACG | 1.55256619 |
18 | MAPK11 | 1.51571286 |
19 | PRKAA2 | 1.42515682 |
20 | MAP3K10 | 1.37900087 |
21 | SIK1 | 1.37162653 |
22 | TESK2 | 1.37111579 |
23 | PDPK1 | 1.35357566 |
24 | EPHA4 | 1.32932354 |
25 | PTK6 | 1.29096587 |
26 | GRK6 | 1.28738654 |
27 | MAP3K1 | 1.26292020 |
28 | MAP3K12 | 1.19667363 |
29 | EPHB1 | 1.18750469 |
30 | ERBB2 | 1.18159566 |
31 | PDK2 | 1.17535526 |
32 | AKT3 | 1.16780071 |
33 | DYRK1B | 1.16064181 |
34 | MYLK | 1.06490246 |
35 | MET | 1.03951837 |
36 | TBK1 | 1.01445572 |
37 | NLK | 1.01400477 |
38 | PDK1 | 0.99497337 |
39 | MAP3K11 | 0.93840301 |
40 | KSR2 | 0.89510690 |
41 | PRKCZ | 0.84836331 |
42 | RET | 0.84444065 |
43 | MAP4K1 | 0.82231404 |
44 | JAK1 | 0.81898812 |
45 | ICK | 0.81355723 |
46 | IRAK3 | 0.81266687 |
47 | PINK1 | 0.80759417 |
48 | NEK9 | 0.79871277 |
49 | JAK2 | 0.77709562 |
50 | IGF1R | 0.77709552 |
51 | ABL2 | 0.75890163 |
52 | CSF1R | 0.75734480 |
53 | MAP2K4 | 0.75024564 |
54 | OXSR1 | 0.74269622 |
55 | MAP2K2 | 0.74210184 |
56 | CDK6 | 0.72434836 |
57 | STK39 | 0.67513536 |
58 | MATK | 0.64599208 |
59 | PRKCA | 0.63846128 |
60 | FER | 0.62025243 |
61 | IRAK1 | 0.56516910 |
62 | DDR2 | 0.55088351 |
63 | PRKACA | 0.51430870 |
64 | ZAP70 | 0.50655513 |
65 | BCKDK | 0.49950479 |
66 | MAP2K6 | 0.48953010 |
67 | SRC | 0.48729642 |
68 | PRKG1 | 0.48606629 |
69 | MAP3K5 | 0.48091834 |
70 | PRKAA1 | 0.46609155 |
71 | CDC42BPA | 0.46297805 |
72 | PIM1 | 0.45979656 |
73 | RIPK4 | 0.43389121 |
74 | PDGFRA | 0.43059524 |
75 | MAP3K6 | 0.41707605 |
76 | PKN2 | 0.41383627 |
77 | TAOK1 | 0.41320501 |
78 | TNIK | 0.39662117 |
79 | ADRBK2 | 0.38919220 |
80 | TAOK3 | 0.37636140 |
81 | FRK | 0.37464481 |
82 | PRKCB | 0.36778978 |
83 | YES1 | 0.34429059 |
84 | MAP3K14 | 0.32642908 |
85 | PRKCG | 0.31956827 |
86 | DAPK2 | 0.31557569 |
87 | FYN | 0.31416979 |
88 | LMTK2 | 0.30622231 |
89 | EEF2K | 0.30616837 |
90 | PRKCD | 0.30056543 |
91 | BMPR2 | 0.29770076 |
92 | SGK1 | 0.29392294 |
93 | SGK223 | 0.29356295 |
94 | SGK494 | 0.29356295 |
95 | IKBKE | 0.28742562 |
96 | MAPK7 | 0.28589383 |
97 | MAPK4 | 0.27956802 |
98 | SGK3 | 0.26597203 |
99 | GSK3A | 0.25267672 |
100 | MAPKAPK3 | 0.24595706 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.47322200 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.55144779 |
3 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.34512540 |
4 | Retinol metabolism_Homo sapiens_hsa00830 | 3.33983910 |
5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.22067779 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.94968491 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.94777524 |
8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.93682172 |
9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.88359358 |
10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.86495911 |
11 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.79619368 |
12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.77347247 |
13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.58411052 |
14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48857079 |
15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.36499019 |
16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.26633861 |
17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.19974486 |
18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.09275670 |
19 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.09018794 |
20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.08556990 |
21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.03658499 |
22 | Bile secretion_Homo sapiens_hsa04976 | 1.98179358 |
23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.88767816 |
24 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.87849887 |
25 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.85614581 |
26 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.77562261 |
27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.76030308 |
28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70498963 |
29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.66230208 |
30 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.38233807 |
31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.25830870 |
32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25051231 |
33 | Peroxisome_Homo sapiens_hsa04146 | 1.16013861 |
34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.15693778 |
35 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.11557727 |
36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06176410 |
37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.05430432 |
38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.03588697 |
39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01472763 |
40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.98055561 |
41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.97240140 |
42 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95216861 |
43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.94961951 |
44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93445522 |
45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89095067 |
46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87523273 |
47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.87387292 |
48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.84403126 |
49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.81852398 |
50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.80661489 |
51 | Mineral absorption_Homo sapiens_hsa04978 | 0.79378204 |
52 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77294051 |
53 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76193052 |
54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75443763 |
55 | ABC transporters_Homo sapiens_hsa02010 | 0.75345748 |
56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.74106344 |
57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70353590 |
58 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.69727812 |
59 | Prion diseases_Homo sapiens_hsa05020 | 0.69218096 |
60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68892128 |
61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67433689 |
62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.67395437 |
63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63672815 |
64 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.62063982 |
65 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.38678812 |
66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36508741 |
67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.35407157 |
68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33039612 |
69 | Insulin resistance_Homo sapiens_hsa04931 | 0.32295388 |
70 | Lysine degradation_Homo sapiens_hsa00310 | 0.27777279 |
71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24206010 |
72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.22821163 |
73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.21549032 |
74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21140600 |
75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21073730 |
76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.20361236 |
77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18835893 |
78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.18789563 |
79 | Pertussis_Homo sapiens_hsa05133 | 0.18042196 |
80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12493742 |
81 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.11272793 |
82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.11133863 |
83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.07922573 |
84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04812271 |
85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.00326904 |
86 | Cocaine addiction_Homo sapiens_hsa05030 | -0.2165421 |
87 | Hepatitis C_Homo sapiens_hsa05160 | -0.1979108 |
88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1939848 |
89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1497162 |
90 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.1395231 |
91 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.1341187 |
92 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1338293 |
93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1309886 |
94 | Amoebiasis_Homo sapiens_hsa05146 | -0.1040410 |
95 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0824665 |
96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0823662 |
97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0796138 |
98 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0446107 |
99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0344302 |
100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0221241 |